Curanex Pharma underwriters exercise full over-allotment; additional $2.25M raised

Curanex Pharmaceuticals Inc

Over-allotment option exercised in full; 562,500 shares at $4.00, raising additional $2.25M.
Total IPO gross proceeds: $17.25M from 4,312,500 shares.
Shares outstanding after overallotment: 28,312,500.
Lead underwriter Dominari Securities; co-underwriters Pacific Century and Revere.
Company advances botanical drug Phyto-N for inflammatory diseases, targeting Phase I.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.